Literature DB >> 8591825

Glucose intolerance, hyperinsulinaemia and cognitive function in a general population of elderly men.

S Kalmijn1, E J Feskens, L J Launer, T Stijnen, D Kromhout.   

Abstract

Cognitive impairment is highly prevalent among the elderly. Subjects with disturbed glucose metabolism may be at risk of impaired cognitive function, as these disturbances can influence cognition through atherosclerosis, thrombosis and hypertension. We therefore studied the cross-sectional association of cognitive function with hyperinsulinaemia, impaired glucose tolerance and diabetes mellitus in a population-based cohort of 462 men aged 69 to 89 years. Cognitive function was measured by the 30-point Mini-Mental State Examination. Results were expressed as the rate ratio (95% confidence interval) of the number of erroneous answers given on the Mini-Mental State Examination by the index compared to the reference group. Compared to subjects with normal glucose tolerance, known diabetic patients had a rate ratio of 1.23 (1.04-1.46), newly-diagnosed diabetic patients of 1.16 (0.91-1.48) and subjects with impaired glucose tolerance of 1.18 (0.98-1.41), after adjustment for confounding due to age, occupation and cigarette smoking (p-trend = 0.01). Non-diabetic subjects in the highest compared to the lowest quartile of the area under the insulin curve had a rate ratio of 1.24 (1.03-1.50), after adjustment for confounding (p-trend = 0.02). The results did not change appreciably when potentially mediating factors, including cardiovascular diseases and risk factors associated with the insulin resistance syndrome, were taken into account. These results suggest that diabetes, as well as impaired glucose tolerance and hyperinsulinaemia in non-diabetic subjects are associated with cognitive impairment.

Entities:  

Mesh:

Year:  1995        PMID: 8591825     DOI: 10.1007/bf00402181

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  31 in total

1.  Epidemiological studies related to coronary heart disease: characteristics of men aged 40-59 in seven countries.

Authors:  A Keys; C Aravanis; H W Blackburn; F S Van Buchem; R Buzina; B D Djordjević; A S Dontas; F Fidanza; M J Karvonen; N Kimura; D Lekos; M Monti; V Puddu; H L Taylor
Journal:  Acta Med Scand Suppl       Date:  1966

Review 2.  Diabetes mellitus. Report of a WHO Study Group.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1985

3.  An epidemiological approach to describing risk associated with blood pressure levels. Final report of the Working Group on Risk and High Blood Pressure.

Authors: 
Journal:  Hypertension       Date:  1985 Jul-Aug       Impact factor: 10.190

4.  Determination of serum triglycerides by an accurate enzymatic method not affected by free glycerol.

Authors:  D R Sullivan; Z Kruijswijk; C E West; M Kohlmeier; M B Katan
Journal:  Clin Chem       Date:  1985-07       Impact factor: 8.327

5.  Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man.

Authors:  J W Rowe; J B Young; K L Minaker; A L Stevens; J Pallotta; L Landsberg
Journal:  Diabetes       Date:  1981-03       Impact factor: 9.461

Review 6.  Cognitive function in diabetes mellitus.

Authors:  J T Richardson
Journal:  Neurosci Biobehav Rev       Date:  1990       Impact factor: 8.989

7.  Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up.

Authors:  A Fontbonne; M A Charles; N Thibult; J L Richard; J R Claude; J M Warnet; G E Rosselin; E Eschwège
Journal:  Diabetologia       Date:  1991-05       Impact factor: 10.122

8.  A longitudinal study of cognitive performance in noninsulin dependent (type II) diabetic men.

Authors:  E A Robertson-Tchabo; D Arenberg; J D Tobin; J B Plotz
Journal:  Exp Gerontol       Date:  1986       Impact factor: 4.032

9.  Decreased cognitive function in aging non-insulin-dependent diabetic patients.

Authors:  L C Perlmuter; M K Hakami; C Hodgson-Harrington; J Ginsberg; J Katz; D E Singer; D M Nathan
Journal:  Am J Med       Date:  1984-12       Impact factor: 4.965

10.  Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. The ECAT Angina Pectoris Study Group.

Authors:  I Juhan-Vague; S G Thompson; J Jespersen
Journal:  Arterioscler Thromb       Date:  1993-12
View more
  49 in total

Review 1.  The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment.

Authors:  G Stennis Watson; Suzanne Craft
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 2.  Impact of postprandial glycaemia on health and prevention of disease.

Authors:  E E Blaak; J-M Antoine; D Benton; I Björck; L Bozzetto; F Brouns; M Diamant; L Dye; T Hulshof; J J Holst; D J Lamport; M Laville; C L Lawton; A Meheust; A Nilson; S Normand; A A Rivellese; S Theis; S S Torekov; S Vinoy
Journal:  Obes Rev       Date:  2012-07-11       Impact factor: 9.213

Review 3.  Central nervous system involvement in diabetes mellitus.

Authors:  Dinesh Selvarajah; Solomon Tesfaye
Journal:  Curr Diab Rep       Date:  2006-12       Impact factor: 4.810

4.  Type 2 diabetes is negatively associated with Alzheimer's disease neuropathology.

Authors:  Michal Schnaider Beeri; Jeremy M Silverman; Kenneth L Davis; Deborah Marin; Hillel Z Grossman; James Schmeidler; Dushyant P Purohit; Daniel P Perl; Michael Davidson; Richard C Mohs; Vahram Haroutunian
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2005-04       Impact factor: 6.053

5.  Inhibition of synaptophysin ubiquitination may improve the intelligent drop due to high glucose and hypoxia.

Authors:  Qiang Li; Xiao-Long Zhu; Ai-Ping Jin; Xue-Yuan Liu; Yan-Xin Zhao
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 6.  Vascular basis for brain degeneration: faltering controls and risk factors for dementia.

Authors:  Raj N Kalaria
Journal:  Nutr Rev       Date:  2010-12       Impact factor: 7.110

7.  Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis.

Authors:  M A Beydoun; H A Beydoun; Y Wang
Journal:  Obes Rev       Date:  2008-03-06       Impact factor: 9.213

Review 8.  Toward a model of memory enhancement in schizophrenia: glucose administration and hippocampal function.

Authors:  William S Stone; Larry J Seidman
Journal:  Schizophr Bull       Date:  2007-05-15       Impact factor: 9.306

9.  Plasma C-peptide levels and rates of cognitive decline in older, community-dwelling women without diabetes.

Authors:  Olivia I Okereke; Michael N Pollak; Frank B Hu; Susan E Hankinson; Dennis J Selkoe; Francine Grodstein
Journal:  Psychoneuroendocrinology       Date:  2008-02-07       Impact factor: 4.905

Review 10.  Type 2 diabetes and risk of cognitive impairment and dementia.

Authors:  Rachel A Whitmer
Journal:  Curr Neurol Neurosci Rep       Date:  2007-09       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.